H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)
Go back to H.C. Wainwright Reiterates Buy Rating on Lineage Cell Therapeutics Inc. (LCTX)| (NYSE: LCTX) | Delayed: 1.24 +0.03 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.22 | 52 Week Low | $ | |||
| Day High | $1.24 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $ | |||
| Volume | 303,115 | |||||
